ABN AMRO Bank’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $483K | Sell |
914
-220,569
| -100% | -$117M | 0.01% | 144 |
|
|
2025
Q1 | $140M | Buy |
221,483
+1,614
| +0.7% | +$1.02M | 1.94% | 23 |
|
|
2024
Q4 | $155M | Buy |
219,869
+6,247
| +3% | +$4.4M | 2.09% | 21 |
|
|
2024
Q3 | $223M | Buy |
213,622
+8,359
| +4% | +$8.72M | 3.05% | 14 |
|
|
2024
Q2 | $218M | Buy |
205,263
+6,353
| +3% | +$6.75M | 3.3% | 10 |
|
|
2024
Q1 | $192M | Buy |
198,910
+182,099
| +1,083% | +$175M | 2.86% | 14 |
|
|
2023
Q4 | $14.8M | Sell |
16,811
-241
| -1% | -$213K | 0.24% | 52 |
|
|
2023
Q3 | $14M | Buy |
17,052
+16,164
| +1,820% | +$13.3M | 0.25% | 50 |
|
|
2023
Q2 | $637K | Buy |
+888
| New | +$637K | 0.01% | 117 |
|